Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement

Thromb Res. 2015 Sep;136(3):669-72. doi: 10.1016/j.thromres.2015.07.003. Epub 2015 Jul 18.

Abstract

Background: Reversal of anticoagulation can be needed in patients undergoing heart valve surgery. ROTEM® has been correlated with international normalized ratio (INR) in patients on warfarin but not with patients on acenocoumarol. This study investigates the reliability of ROTEM® for detecting INR values below the 1.5 threshold in patients on acenocoumarol therapy.

Material and methods: Patients on oral anticoagulation with acenocoumarol after elective heart valve replacement were prospectively included in the study. INR and the ROTEM® were measured simultaneously. ROTEM® parameters included coagulation time, clot formation time, alpha angle, and maximal clot firmness after tissue factor activation (EXTEM). Concordance between INR and ROTEM® was analyzed by Lin's concordance coefficient (LCC) and the correlation with Spearman's rho.

Results: Fifty-four consecutive patients (40 female; median age 67years) were included. Clotting time (CT) was the parameter that best correlated with INR (r=0.81, p<0,001), and LCC was substantial (0.67). CT was able to predict INR values above or below 1.5: area under curve=0.998. CT≥84seconds, corresponding to a cut-off for likelihood ratio (LR+)=5, had a sensitivity and specificity of 100% and 80%, respectively, to detect an INR below 1.5. For the same INR threshold, CT≥84seconds had a predictive positive value of 92.9% and a predictive negative value of 100%.

Conclusion: Our preliminary results suggest that CT≥84seconds in the EXTEM ROTEM® test is a feasible method for predicting an insufficient reversion of oral anticoagulant therapy in patients taking acenocoumarol after elective heart valve surgery.

Keywords: acenocumarol; thromboelastometry.

Publication types

  • Clinical Trial

MeSH terms

  • Acenocoumarol / administration & dosage*
  • Acenocoumarol / adverse effects
  • Aged
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Drug Administration Schedule
  • Drug Monitoring / methods
  • Drug Tolerance
  • Elective Surgical Procedures*
  • Female
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Postoperative Hemorrhage / blood*
  • Postoperative Hemorrhage / prevention & control*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Thrombelastography / methods*
  • Thromboembolism / blood
  • Thromboembolism / diagnosis
  • Thromboembolism / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Acenocoumarol